Literature DB >> 16962478

Permanent pacing after cardiac transplantation in the era of extended donors.

Shelley Zieroth1, Heather Ross, Vivek Rao, Diego H Delgado, Robert J Cusimano, Mathura Thevarajah, Douglas A Cameron, Kumaraswamy Nanthakumar.   

Abstract

BACKGROUND: Early results with bicaval anastomosis have shown a decreased requirement for permanent pacing (PPM) after transplantation (Tx). It is unclear whether this remains true in the current era of extended donor criteria. The objective of the present study was to characterize the need for post-Tx PPM requirements in the current bicaval era and to determine factors associated with need for pacing.
METHODS: The local cardiac Tx database, hospital records and electrophysiology laboratory database were cross-referenced for information on patients in the pre-, peri- and post-Tx period.
RESULTS: Between 2000 and 2004, 88 patients received a cardiac Tx using bicaval anastomosis. At post-Tx, 18 of 88 (20.5%) patients required a PPM. The incidence of single- and dual-chamber PPM was 31.3% and 68.7%, respectively. Mean donor age for patients requiring post-Tx PPM was 44.7 +/- 15.3 years compared with 35.7 +/- 14.4 years for those with no PPM requirement (p = 0.019). For every 5-year increase in donor age the risk for post-Tx PPM increased 1.234-fold (95% confidence interval [CI] 1.022 to 1.489, p = 0.0289). Recipient age, gender, amiodarone use, year of transplant, surgeon and surgical times were not associated with PPM requirements after cardiac Tx.
CONCLUSIONS: Pacing requirements after heart transplantation, in the era of extended donor criteria, exceed the previously published rates of 0% to 5%. The advantage of bicaval anastomosis in decreasing pacing needs post-Tx does not exist in the era of extended donor criteria, specifically in the older donor age group.

Entities:  

Mesh:

Year:  2006        PMID: 16962478     DOI: 10.1016/j.healun.2006.07.003

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

Review 1.  Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.

Authors:  Douglas L Jennings; Brandon Martinez; Sheila Montalvo; David E Lanfear
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

2.  Pacemaker Use Following Heart Transplantation.

Authors:  Hari R Mallidi; Michael Bates
Journal:  Ochsner J       Date:  2017

3.  Posttransplant pacemaker placement: case series and review.

Authors:  Mark A Thompson; Hamang Patel
Journal:  Ochsner J       Date:  2010

4.  Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.

Authors:  Lauren B Cooper; Robert J Mentz; Leah B Edwards; Amber R Wilk; Joseph G Rogers; Chetan B Patel; Carmelo A Milano; Adrian F Hernandez; Josef Stehlik; Lars H Lund
Journal:  J Heart Lung Transplant       Date:  2016-07-17       Impact factor: 10.247

5.  Risk factors and survival of patients with permanent pacemaker implantation after heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Andreas O Doesch; Philipp Ehlermann; Hugo A Katus; Edgar Zitron
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

6.  Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Hugo A Katus; Andreas O Doesch
Journal:  Drug Des Devel Ther       Date:  2017-06-19       Impact factor: 4.162

7.  Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post-transplant mortality.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Andreas O Doesch; Philipp Ehlermann; Hugo A Katus; Edgar Zitron
Journal:  ESC Heart Fail       Date:  2020-07-01

8.  Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation.

Authors:  Stefan Roest; Olivier C Manintveld; Marit A E Kolff; Ferdi Akca; Jesse F Veenis; Alina A Constantinescu; Jasper J Brugts; Ozcan Birim; Lennie M van Osch-Gevers; Tamas Szili-Torok; Kadir Caliskan
Journal:  ESC Heart Fail       Date:  2022-02-17

9.  Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival.

Authors:  Salman S Allana; Furqan A Rajput; Jason W Smith; Lucian Lozonschi; Jinn-Ing Liou; Maryl Johnson; Takushi Kohmoto; Ravi Dhingra
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-19       Impact factor: 3.727

10.  Arrhythmias after heart transplantation: mechanisms and management.

Authors:  Anees Thajudeen; Eric C Stecker; Michael Shehata; Jignesh Patel; Xunzhang Wang; John H McAnulty; Jon Kobashigawa; Sumeet S Chugh
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.